Chemistry:Aloracetam
From HandWiki
Revision as of 20:04, 16 July 2022 by imported>WikiG (change)
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C11H16N2O2 |
| Molar mass | 208.261 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Aloracetam (INN) is a drug described as a nootropic which is closely related to, but technically not of (as it lacks a pyrrolidone ring), the racetam family of compounds.[1][2][3] It was studied by Aventis for the treatment of Alzheimer's disease,[4] but was never marketed.
See also
References
- ↑ "The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances". World Health Organization. 2011. https://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf. Retrieved 22 May 2015.
- ↑ Drug Therapy in Old Age. Wiley. 7 July 1998. ISBN 978-0-471-94149-1. https://books.google.com/books?id=pTVsAAAAMAAJ.
- ↑ Dictionary of Pharmacological Agents. CRC Press. 21 November 1996. pp. 615–. ISBN 978-0-412-46630-4. https://books.google.com/books?id=Z_mfTTIApVEC&pg=PA615.
- ↑ "List of drugs in development for neurodegenerative diseases". Neuro-Degenerative Diseases 1 (1): 50–70. 2004. doi:10.1159/000077879. PMID 16908974.
 |  |
